UM

Browse/Search Results:  1-7 of 7 Help

Selected(0)Clear Items/Page:    Sort:
Epigenetic targeting drugs potentiate chemotherapeutic effects in solid tumor therapy Journal article
SCIENTIFIC REPORTS, 2017,Volume: 7
Authors:  Li, Jingjing;  Hao, Dapeng;  Wang, Li;  Wang, Haitao;  Wang, Yuan;  Zhao, Zhiqiang;  Li, Peipei;  Deng, Chuxia;  Di, Li-Jun
Favorite |  | TC[WOS]:25 TC[Scopus]:27 | Submit date:2018/10/30
Electroconvulsive therapy for agitation in schizophrenia: metaanalysis of randomized controlled trials Journal article
Shanghai Archives of Psychiatry, 2017,Volume: 29,Issue: 1,Page: 1-14
Authors:  Gu X.;  Zheng W.;  Guo T.;  Ungvari G.S.;  Chiu H.F.K.;  Cao X.;  D'Arcy C.;  Meng X.;  Ning Y.;  Xiang Y.
Favorite |  | TC[WOS]:0 TC[Scopus]:4 | Submit date:2018/12/18
Agitation  Electroconvulsive therapy  Headache, meta-analysis  Schizophrenia  
Wuling capsule for major depressive disorder: A meta-analysis of randomised controlled trials Journal article
East Asian Archives of Psychiatry, 2016,Volume: 26,Issue: 3,Page: 87-97
Authors:  Zheng W.;  Zhang Y.F.;  Zhong H.Q.;  Mai S.M.;  Yang X.H.;  Xiang Y.T.
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2018/12/18
Antidepressive agents  Depressive disorder major  Drugs Chinese herbal  
Electroconvulsive therapy added to non-clozapine antipsychotic medication for treatment resistant schizophrenia: Meta-analysis of randomized controlled trials Journal article
PLoS ONE, 2016,Volume: 11,Issue: 6
Authors:  Zheng W.;  Cao X.-L.;  Ungvari G.S.;  Xiang Y.-Q.;  Guo T.;  Liu Z.-R.;  Wang Y.-Y.;  Forester B.P.;  Seiner S.J.;  Xiang Y.-T.
Favorite |  | TC[WOS]:21 TC[Scopus]:22 | Submit date:2018/12/18
Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: Results from a systematic review and meta-analysis of randomized controlled trials Journal article
Expert Opinion on Drug Safety, 2016,Volume: 15,Issue: 5,Page: 591-612
Authors:  Galling,Britta;  Roldán,Alexandra;  Rietschel,Liz;  Hagi,Katsuhiko;  Walyzada,Frozan;  Zheng,Wei;  Cao,Xiao Lan;  Xiang,Yu Tao;  Kane,John M.;  Correll,Christoph U.
Favorite |  | TC[WOS]:19 TC[Scopus]:22 | Submit date:2021/03/02
adverse effects  Antipsychotics  augmentation  combination  cotreatment  metaanalysis  monotherapy  polypharmacy  safety  schizophrenia  tolerability  
Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials Journal article
EXPERT OPINION ON DRUG SAFETY, 2016,Volume: 15,Issue: 5,Page: 591-612
Authors:  Galling, B;  Roldan, A;  Rietschel, L;  Hagi, K;  Walyzada, F;  Zheng, W;  Cao, XL;  Xiang, YT;  Kane, JM;  Correll, CU
Favorite |  | TC[WOS]:19 TC[Scopus]:22 | Submit date:2019/01/07
Monotherapy  Metaanalysis  Antipsychotics  Augmentation  Combination  Polypharmacy  Cotreatment  Adverse Effects  Tolerability  Safety  Schizophrenia  
Glycaemic control efficacy of oral antidiabetic drugs in treating type 2 diabetes: A protocol for network meta-analysis Journal article
BMJ Open, 2015,Volume: 5,Issue: 3
Authors:  Jia Y.;  Lao Y.;  Leung S.-W.
Favorite |  | TC[WOS]:2 TC[Scopus]:2 | Submit date:2019/01/15